P160025S013

None

FDA Premarket Approval P160025 S013

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP160025S013
Classification NameNone
Applicant
PMAP160025
SupplementS013

Supplemental Filings

Supplement NumberDateSupplement Type
P160025Original Filing
S015 2022-06-21 30-day Notice
S014 2022-04-20 30-day Notice
S013
S012 2021-09-15 30-day Notice
S011 2021-04-08 30-day Notice
S010 2021-03-25 30-day Notice
S009 2019-11-04 30-day Notice
S008 2019-07-15 30-day Notice
S007
S006 2018-07-10 30-day Notice
S005 2018-06-21 Normal 180 Day Track No User Fee
S004 2018-04-16 30-day Notice
S003 2017-10-11 30-day Notice
S002 2017-06-14 Normal 180 Day Track No User Fee
S001 2017-04-19 135 Review Track For 30-day Notice

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.